Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications

Surgery Today

Volumn 34, Issue 11, 2004, Pages 913-919

  Nanashima, Atsushi ^a   Yamaguchi, Hiroyuki ^a   Tanaka, Kenji ^a   Shibasaki, Shinichi ^a   Tsuji, Takashi ^a   Ide, Noboru ^a   Hidaka, Shigekazu ^a   Sawai, Terumitsu ^a   Nakagoe, Tohru ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Ascites; Hepatic failure; Hyaluronic acid; Liver resection; Prognostic marker

Indexed keywords

HYALURONIC ACID; TECHNETIUM 99M; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASCITES; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; HUMAN; LIVER FAILURE; LIVER RESECTION; LIVER SCINTISCANNING; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; ANALYSIS OF VARIANCE; BLOOD; CANCER STAGING; LIVER REGENERATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HEPATECTOMY; HUMANS; HYALURONIC ACID; LIVER NEOPLASMS; LIVER REGENERATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 20044366162     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-004-2845-y     Document Type: Article

References (35)

1. Herold C, Heinz R, Niedobitek G, Schneider T, Hahn EG, Schuppan D. Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C. Liver 2001;21: 260-5.
2. Herold C, Ganslmayer M, Deynet C, Hahn EG, Schuppan D. Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis. Liver 2002;22: 159-65.
3. Miyazaki S, Takasaki K, Yamamoto M, Tsugita M, Otsubo T. Liver regeneration and restoration of liver function after partial hepatectomy: the relation of fibrosis of the liver parenchyma. Hepato-Gastroenterology 1999;46:2919-24.
4. Pontinha N, Pessegueiro H, Barros H. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scand J Clin Lab Invest 1999;59:343-7.
5. Idobe Y, Murawaki Y, Ikuta Y, Koda M, Kawasaki H. Postprandial serum hyaluronan concentration in patients with chronic liver disease. Intern Med 1998;37:568-75.
6. Ramadori G, Zohrens G, Manns M, Rieder H, Dienes HP, Hess G, et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991;21: 323-30.
7. Tamaki S, Ueno T, Torimura T, Sata M, Tanikawa K. Evaluation of hyaluronic acid binding ability of hepatic sinusoidal endothelial cells in rats with liver cirrhosis. Gastroenterology 1996;111:1049-57.
8. Yoshidome H, Miyazaki M, Shimizu H, Ito H, Nakagawa K, Ambiru S, et al. Obstructive jaundice impairs hepatic sinusoidal endothelial cell function and renders liver susceptible to hepatic ischemia/reperfusion. Hepatology 2000;33:59-67.
9. Nanashima A, Yamaguchi A, Shibasaki S, Sawai T, Yamaguchi E, Yasutake T, et al. Measurement of serum hyaluronic acid level during the perioperative period of liver resection for evaluation of functional liver reserve. J Gastroenterol Hepatol 2001;16:1158-63.
10. Suehiro T, Boros P, Emre S, Sheiner P, Guy S, Schwartz ME, et al. Assessment of liver allograft function by hyaluronic acid and endothelin levels. J Surg Res 1997;73:123-8.
11. Ogata T, Okuda K, Ueno T, Saito N, Aoyagi S. Serum hyaluronan as a predictor of hepatic regeneration after hepatectomy in humans. Eur J Clin Invest 1999;29:778-85.
12. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 1998;83:2302-11.
13. Takasaki T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, et al. Predetermining postoperative hepatic function for hepatectomies. Int Surg 1980;65:309-13.
14. Hwang EH, Taki J, Shuke N, Nakajima K, Kinuya S, Konishi S, et al. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999;40:1644-51.
15. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology 1997;26:1176-81.
16. Sakamoto Y, Inoue K, Takayama T, Makuuchi M. Perioperative management for patients with chronic liver injury and the strategy for preventing postoperative liver failure (in Japanese with English abstract). Nihon Geka Gakkaizasshi (J Jpn Surg Soc) 1997;98:663-6A.
17. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
18. Fan ST, Ng IO, Poon RT, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg 1999;134:1124-30.
19. Noguchi T, Imai T, Mizumoto R. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepato-Gastroenterology 1990;37:165-71.
20. Shimizu H, He W, Guo P, Dziadkoviec I, Miyazaki M, Falk RE. Serum hyaluronate in the assessment of liver endothelial cell function after orthotopic liver transplantation in the rat. Hepatology 1994;20:1323-9.
21. Fujioka H, Kawashita W, Kamohara W, Yamashita A, Mizoe A, Yamaguchi J, et al. Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve. J Clin Gastroenterol 1999;28:329-33.
22. Korner T, Kropf J, Gressner AM. Serum laminin and hyaluronan in liver cirrhosis: markers of progression with hgih prognostic value. J Hepatol 1996;25:684-8.
23. Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 1996;11:459-65.
24. Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepatol 1998;5:187-92.
25. Ninomiya T, Yoon S, Hayashi Y, Sugano M, Kumon Y, Seo Y, et al. Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system. J Gastroenterol Hepatol 1998;13:68-74.
26. Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001;36:399-406.
27. Nagasue N, Yukaya H, Ogawa Y, Hirose S, Okita M. Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion. Br J Surg 1985;72:565-8.
28. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993;18: 79-85.
29. Wakabayashi H, Yachida S, Maeba T, Maeta H. Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection. Hepato-Gastroenterology 2002;49:1048-52.
30. Chijiiwa K, Watanabe M, Hachiya W, Kameoka N, Tanaka M. Serum hyaluronic acid level reflects volume and ATP level of the liver after extended hepatectomy with and without preoperative portal vein occlusion. J Surg Res 1997;72:107-11.
31. Wang XD, Andersson R, Soltesz V, Bengmark S. Bacterial translocation after major hepatectomy in patients and rats. Arch Surg 1992;127:1101-6.
32. Namekata K, Morioka K, Takamori S, Kojima K, Fukasawa M, Beppu T, et al. Significant changes in the serum levels of hyaluronic acid during the perioperative period of hepatectomy: relevance to SIRS (in Japanese with English abstract). Nihon Syokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg) 2001;34: 1373-9.
33. Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K. The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 1987;11:678-81.
34. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, et al. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999;86:1032-8.
35. Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K. Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg 1984;199: 51-6.